Innovative management retirement provision

Our management retirement provision offers a flexible pension plan that enables our clients to set up a company pension scheme. This can be tailored to meet the needs of the company and its employees.

Private banking for your pension fund

Our innovative management pension solution offers you tangible and quantifiable benefits.

  • Separation into basic and management pension fund. The splitting of the two vehicles allows for customisation and diversification of investments.
  • No cross-subsidisation in the management pension fund. In the event of death, the pension assets are disbursed to the heirs in full.
  • You can benefit from significant tax optimisation both at the private and the corporate level.
  • Pension plan optimisation in the management pension fund creates greater purchase potential even if your salary stays the same.

Facts at a glance

  • No minimum investment
  • Needs-based choice of strategy
  • Realisation via funds, ETFs and individual stocks
  • Company-specific risk benefits
  • Salary components from CHF 86,040, or from CHF 129,060, depending on specific solution

Our solutions

PensFlex

PensFlex, our innovative management pension solution, offers you tangible and quantifiable benefits.

  • Purchases can be deducted from taxable income in full.
  • On departure from the foundation, for instance on retirement, securities can be transferred to your private assets without necessitating a sale.
  • The splitting allows for a more efficient and tax-optimised staggering of withdrawals.

PensUnit

Our innovative PensUnit solution offers you advantages in a range of areas.

  • Co-determination of the investment strategy
  • No cross-subsidisation
  • Tax relief for the company
  • Private tax optimisation
  • Formation of deductible collective fluctuation reserves

Please do not hesitate to contact us for a consultation

Marco Danelli

Head of Pension

«We are among the pioneers of customised pension solutions in Switzerland.»

Jürg Staub

partner with unlimited liability

News

Swiss pharmaceutical industry facing political headwinds

The pharmaceutical industry is currently high on Donald Trump’s list of priorities. He wants more production and jobs in the US, as well as lower drug prices. As a means of exerting pressure, he is threatening to impose price caps and introduce tariffs on drugs. These goals are, of course, contradictory, which is causing even more uncertainty.

Read more

Market commentary on the US trade conflict with Switzerland

The list of new customs measures against Switzerland, published on the night of Swiss National Day on August 1, came as a surprise. The economic impact of the tariffs is significant.

Read more

Lucerne lacks a foundation culture

For the first time, a study shows how differently cantons exempt foundations from taxes. Zurich recently liberalized its practice. How is Lucerne reacting?

Read more